{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:21:23Z","timestamp":1779193283325,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejphar.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T07:27:58Z","timestamp":1528270078000},"page":"364-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dose-dependent effects of adenosine antagonists on tacrine-induced tremulous jaw movements"],"prefix":"10.1016","volume":"833","author":[{"given":"Joel A.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron P.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Trevitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.06.004_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-007-0844-6","article-title":"The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors","volume":"194","author":"Betz","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2018.06.004_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2009.05.040","article-title":"Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide","volume":"163","author":"Betz","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2018.06.004_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","article-title":"Functional changes of the basal ganglia circuitry in Parkinson's disease","volume":"62","author":"Blandini","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib4","doi-asserted-by":"crossref","first-page":"E3609","DOI":"10.1073\/pnas.1507704112","article-title":"Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer","volume":"112","author":"Bonaventura","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.06.004_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1471-4159.1990.tb08817.x","article-title":"Both A1 and A2a purine receptors regulate striatal acetylcholine release","volume":"55","author":"Brown","year":"1990","journal-title":"J. Neurochem."},{"issue":"Pt 2","key":"10.1016\/j.ejphar.2018.06.004_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1469-7793.1998.421bk.x","article-title":"Muscarinic IPSPs in rat striatal cholinergic interneurones","volume":"510","author":"Calabresi","year":"1998","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-3565(25)09521-7","article-title":"Caffeine enhances acetylcholine release in the hippocampus in vivo by a selective interaction with adenosine A1 receptors","volume":"273","author":"Carter","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.06.004_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pbb.2009.11.011","article-title":"Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX","volume":"94","author":"Collins","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.06.004_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fnsys.2011.00049","article-title":"Pharmacological and physiological characterization of the tremulous jaw movement model of Parkinsonian tremor: potential Insights into the pathophysiology of tremor","volume":"5","author":"Collins-Praino","year":"2011","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.ejphar.2018.06.004_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0091-3057(98)00214-7","article-title":"The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements","volume":"62","author":"Cousins","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.06.004_bib11","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1523\/JNEUROSCI.13-12-05402.1993","article-title":"The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain","volume":"13","author":"Ferre","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.06.004_bib12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1460-9568.1996.tb01617.x","article-title":"Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms","volume":"8","author":"Ferre","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.06.004_bib13","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/138161208784480108","article-title":"An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors","volume":"14","author":"Ferre","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2018.06.004_bib14","article-title":"Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer","author":"Ferr\u00e9","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.06.004_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0091-3057(96)00385-1","article-title":"Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions","volume":"57","author":"Finn","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.06.004_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0022-3565(25)22248-0","article-title":"Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine","volume":"250","author":"Flynn","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.06.004_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/157015907781695946","article-title":"Allosteric modulation of muscarinic acetylcholine receptors","volume":"5","author":"Gregory","year":"2007","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib18","first-page":"7","article-title":"Mechanism of action of cholinesterase inhibitors in Alzheimer's disease","volume":"149","author":"H\u00e5kansson","year":"1993","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.ejphar.2018.06.004_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pbb.2004.12.006","article-title":"Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats","volume":"80","author":"Ishiwari","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.06.004_bib20","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1523\/JNEUROSCI.5073-13.2014","article-title":"Differential effects of presynaptic versus postsynaptic adenosine A2A receptor blockade on Delta9-tetrahydrocannabinol (THC) self-administration in squirrel monkeys","volume":"34","author":"Justinova","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.06.004_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1369-1600.2010.00258.x","article-title":"Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist","volume":"16","author":"Justinov\u00e1","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib22","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1046\/j.1471-4159.1996.66051882.x","article-title":"Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo","volume":"66","author":"Kurokawa","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2018.06.004_bib23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/sj.bjp.0701465","article-title":"Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists","volume":"122","author":"Maemoto","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0091-3057(96)00225-0","article-title":"Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects","volume":"56","author":"Mayorga","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.06.004_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.molbrainres.2004.09.012","article-title":"Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice","volume":"133","author":"Oki","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ejphar.2018.06.004_bib26","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/sj.bjp.0703366","article-title":"Adenosine receptor expression and function in rat striatal cholinergic interneurons","volume":"130","author":"Preston","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib27","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.euroneuro.2012.08.004","article-title":"Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor","volume":"23","author":"Salamone","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2018.06.004_bib28","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.parkreldis.2008.04.017","article-title":"Dopamine\/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism","volume":"14","author":"Salamone","year":"2008","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ejphar.2018.06.004_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0301-0082(98)00053-7","article-title":"Tremulous jaw movements in rats: a model of parkinsonian tremor","volume":"56","author":"Salamone","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2004.05.027","article-title":"Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions","volume":"189","author":"Simola","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2006.05.038","article-title":"Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease","volume":"248","author":"Simola","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejphar.2018.06.004_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pbb.2009.07.001","article-title":"Differential effects of adenosine antagonists in two models of parkinsonian tremor","volume":"94","author":"Trevitt","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.06.004_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pbb.2009.02.001","article-title":"Adenosine antagonists reverse the cataleptic effects of haloperidol: implications for the treatment of Parkinson's disease","volume":"92","author":"Trevitt","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.06.004_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/mol.64.1.180","article-title":"Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors","volume":"64","author":"Tr\u00e4nkle","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib35","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1124\/mol.105.019141","article-title":"Allosteric binding sites on muscarinic acetylcholine receptors","volume":"68","author":"Wess","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(00)00005-4","article-title":"Presynaptic nicotinic receptors modulating dopamine release in the rat striatum","volume":"393","author":"Wonnacott","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.06.004_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuroscience.2006.04.047","article-title":"Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum","volume":"141","author":"Yabuuchi","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2018.06.004_bib38","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1523\/JNEUROSCI.16-08-02592.1996","article-title":"Muscarinic (m2\/m4) receptors reduce N- and P-type Ca2+ currents in rat neostriatal cholinergic interneurons through a fast, membrane-delimited, G-protein pathway","volume":"16","author":"Yan","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.06.004_bib39","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1523\/JNEUROSCI.22-05-01709.2002","article-title":"Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice","volume":"22","author":"Zhang","year":"2002","journal-title":"J. Neurosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:18:54Z","timestamp":1751674734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918303212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":39,"alternative-id":["S0014299918303212"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.06.004","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-dependent effects of adenosine antagonists on tacrine-induced tremulous jaw movements","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}